middle.news
How Algorae’s New Licensing Deals Could Transform Its Market Presence
9:08am on Tuesday 28th of October, 2025 AEDT
•
Pharmaceuticals
Read Story
How Algorae’s New Licensing Deals Could Transform Its Market Presence
9:08am on Tuesday 28th of October, 2025 AEDT
Key Points
Signed licensing deals for seven generic medicines with Sakar Healthcare and Cadila Pharmaceuticals
Advanced AlgoraeOS Version 2.0 AI platform into final testing phase
Progressed pre-clinical development of dementia and cardiovascular drug candidates
Appointed David Gulland as Chief Operating Officer to boost commercial growth
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Algorae Pharmaceuticals (ASX:1AI)
OPEN ARTICLE